AMN:NYE-AMN Healthcare Services, Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 74.20

Change

-2.09 (-2.74)%

Market Cap

USD 3.49B

Volume

0.20M

Average Target Price

USD 83.57 (+12.63%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing under the American Mobile, Onward Healthcare, Nurses Rx, Advanced, and O'Grady-Peyton brands; nurse staffing and labor disruption services; local, or per diem, staffing for daily shift work under the Nursefinders brand; and locum tenens staffing for specialties, clinicians, and dentists on an independent contractor basis on temporary assignments under the Staff Care and Locum Leaders brands. It also provides allied staffing services, such as skilled nursing facilities, rehabilitation clinics, and retail and mail-order pharmacies; physician permanent placement services to hospitals, healthcare facilities, and physician practice groups, as well as physician executive leadership search services; and executive and clinical leadership interim staffing, healthcare executive search, and advisory services. In addition, it offers managed services programs; vendor management systems; recruitment process outsourcing for permanent hiring needs; workforce optimization services comprising consulting, data analytics, predictive modeling, and SaaS-based scheduling technology under the Smart Square brand; medical coding, clinical documentation improvement, case management, clinical data registry, and auditing and advisory services; digital staffing services; flex pool management; and credentialing software solutions to clinicians and healthcare enterprises. The company serves acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools, and various other healthcare settings. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Taxas. Address: 8840 Cypress Waters Boulevard, Dallas, TX, United States, 75019

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-03-02 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare, Inc

+2.72 (+1.55%)

USD60.54B 16.29 9.22
FMS Fresenius Medical Care AG & Co..

+0.30 (+0.86%)

USD20.70B 9.57 8.17
OSH Oak Street Health, Inc

+2.61 (+5.02%)

USD12.77B N/A N/A
DVA DaVita Inc

+0.67 (+0.65%)

USD11.27B 16.40 9.75
UHS Universal Health Services, Inc

+1.45 (+1.13%)

USD10.87B 11.64 7.51
EHC Encompass Health Corporation

+0.46 (+0.58%)

USD7.98B 28.23 12.58
CHE Chemed Corporation

-3.85 (-0.86%)

USD7.09B 22.69 15.55
THC Tenet Healthcare Corporation

+0.30 (+0.57%)

USD5.62B 14.10 7.38
SEM Select Medical Holdings Corpor..

+0.49 (+1.49%)

USD4.44B 17.09 9.93
MD MEDNAX, Inc

+0.51 (+2.08%)

USD2.10B 9.15 18.26

ETFs Containing AMN

Symbol Name Weight Mer Price(Change) Market Cap
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

-3.44 (-1.84%)

USD0.51B
HERS:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

USD3.37M
JSML Janus Henderson Small Cap.. 0.00 % 0.30 %

-0.69 (-1.01%)

USD0.08B
HERS-B:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.72% 52% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.72% 52% F 65% D
Trailing 12 Months  
Capital Gain 2.19% 33% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.19% 29% F 28% F
Trailing 5 Years  
Capital Gain 141.85% 75% C 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 141.85% 75% C 84% B
Average Annual (5 Year Horizon)  
Capital Gain 14.94% 71% C- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.94% 71% C- 83% B
Risk Return Profile  
Volatility (Standard Deviation) 23.15% 48% F 34% F
Risk Adjusted Return 64.53% 81% B- 74% C
Market Capitalization 3.49B 59% F 69% D+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 50.14 11% F 16% F
Price/Book Ratio 4.18 53% F 24% F
Price / Cash Flow Ratio 13.59 18% F 33% F
EV/EBITDA 17.99 30% F 36% F
Management Effectiveness  
Return on Equity 9.08% 39% F 62% D-
Return on Invested Capital 8.46% 55% F 71% C-
Return on Assets 4.83% 68% D+ 78% C+
Debt to Equity Ratio 104.67% 56% F 35% F
Technical Ratios  
Short Ratio 5.18 32% F 12% F
Short Percent 4.04% 45% F 50% F
Beta 0.46 86% B 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector